EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 32013R0944
Commission Regulation (EU) No 944/2013 of 2 October 2013 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures Text with EEA relevance
Regolament tal-Kummissjoni (UE) Nru 944/2013 tat- 2 ta’ Ottubru 2013 li jemenda, għall-finijiet tal-adattament tiegħu għall-progress tekniku u xjentifiku, ir-Regolament (KE) Nru 1272/2008 tal-Parlament Ewropew u tal-Kunsill dwar il-klassifikazzjoni, l-ittikkettar u l-imballaġġ tas-sustanzi u t-taħlitiet Test b’relevanza għaż-ŻEE
Regolament tal-Kummissjoni (UE) Nru 944/2013 tat- 2 ta’ Ottubru 2013 li jemenda, għall-finijiet tal-adattament tiegħu għall-progress tekniku u xjentifiku, ir-Regolament (KE) Nru 1272/2008 tal-Parlament Ewropew u tal-Kunsill dwar il-klassifikazzjoni, l-ittikkettar u l-imballaġġ tas-sustanzi u t-taħlitiet Test b’relevanza għaż-ŻEE
ĠU L 261, 3.10.2013, p. 5–22
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
Relation | Act | Comment | Subdivision concerned | From | To |
---|---|---|---|---|---|
Modifies | 32008R1272 | Emenda | anness IV | 23/10/2013 | |
Modifies | 32008R1272 | Emenda | anness VI P.3 | 23/10/2013 |
Relation | Act | Comment | Subdivision concerned | From | To |
---|---|---|---|---|---|
Corrected by | 32013R0944R(01) | (LV, SV) | |||
Corrected by | 32013R0944R(02) | (CS, IT, RO, SK) | |||
Corrected by | 32013R0944R(03) | (DE) |
3.10.2013 |
MT |
Il-Ġurnal Uffiċjali tal-Unjoni Ewropea |
L 261/5 |
REGOLAMENT TAL-KUMMISSJONI (UE) Nru 944/2013
tat-2 ta’ Ottubru 2013
li jemenda, għall-finijiet tal-adattament tiegħu għall-progress tekniku u xjentifiku, ir-Regolament (KE) Nru 1272/2008 tal-Parlament Ewropew u tal-Kunsill dwar il-klassifikazzjoni, l-ittikkettar u l-imballaġġ tas-sustanzi u t-taħlitiet
(Test b’relevanza għaż-ŻEE)
IL-KUMMISSJONI EWROPEA,
Wara li kkunsidra t-Trattat dwar il-Funzjonament tal-Unjoni Ewropea,
Wara li kkunsidrat ir-Regolament (KE) Nru 1272/2008 tal-Parlament Ewropew u tal-Kunsill tas-16 ta’ Diċembru 2008 dwar il-klassifikazzjoni, l-ittikkettar u l-imballaġġ tas-sustanzi u t-taħlitiet, li jemenda u jħassar id-Direttivi 67/548/KEE u 1999/45/KE, u li jemenda r-Regolament (KE) Nru 1907/2006 (1), u b’mod partikolari l-Artikolu 37(5) u l-Artikolu 53 tiegħu,
Billi:
(1) |
Fir-rigward tad-dikjarazzjoni ta’ prekawzjoni P210 stipulata f’tabella 6.2 Part 1 tal-Anness IV tar-Regolament (KE) Nru 1272/2008 il-5 reviżjoni tas-Sistema Globalment Armonizzata tal-Klassifikazzjoni u l-Ittikettar ta’ Sustanzi Kimiċi (minn hawn ‘il quddiem GHS — Globally Harmonised System) tal-Ġnus Magħquda ġabet bidliet li ma kinux tqiesu fir-Regolament tal-Kummissjoni (UE) Nru 487/2013 (2). Għal raġunijiet ta’ konsistenza huwa neċessarju li jiġi stipulat allinjament sħiħ bejn il-GHS u r-Regolament (KE) Nru 1272/2008. |
(2) |
Il-Parti 3 tal-Anness VI għar-Regolament (KE) Nru 1272/2008 fiha żewġ listi ta’ klassifikazzjoni u ttikkettar armonizzati ta’ sustanzi perikolużi. It-Tabella 3.1 telenka l-klassifikazzjoni u l-ittikkettar armonizzati ta’ sustanzi perikolużi abbażi tal-kriterji stipulati fil-Partijiet 2 sa 5 tal-Anness I għar-Regolament (KE) Nru 1272/2008. It-Tabella 3.2 telenka l-klassifikazzjoni armonizzata u t-tikkettar ta’ sustanzi perikolużi abbażi tal-kriterji stipulati fl-Anness VI għad-Direttiva tal-Kunsill 67/548/KEE tas-27 ta’ Ġunju 1967 rigward l-approssimazzjoni tal-liġijiet, tar-regolamenti u tad-dispożizzjonijiet amministrattivi fir-rigward tal-klassifikazzjoni, l-imballaġġ u t-tikkettar ta’ sustanzi perikolużi (3). Dawk iż-żewġ listi jeħtieġ li jiġu emendati sabiex jinkludu klassifikazzjonijiet aġġornati għal sustanzi li huma diġà suġġetti għal dawk il-klassifikazzjonijiet armonizzati u biex jinkludu klassifikazzjonijiet armonizzati ġodda. |
(3) |
Il-Kumitat għall-Valutazzjoni tar-Riskji (RAC—Committee for Risk Assessment) tal-Aġenzija Ewropea għas-Sustanzi Kimiċi (ECHA – European Chemicals Agency) ħareġ opinjonijiet fuq proposti għal klassifikazzjoni u ttikkettar armonizzati ta’ sustanzi li kienu ġew ippreżentati lill-ECHA skont l-Artikolu 37 għar-Regolament (KE) Nru 1272/2008. Abbażi ta’ dawn l-opinjonijiet, kif ukoll tal-kummenti mibgħuta min-naħa tal-partijiet ikkonċernati, huwa f’loku li jiġi emendat l-Anness VI għar-Regolament (KE) Nru 1272/2008 sabiex jiġu armonizzati l-klassifikazzjoni u l-ittikkettar ta’ ċerti sustanzi. |
(4) |
Il-klassifikazzjonijiet armonizzati stipulati fil-Parti 3 tal-Anness VI għar-Regolament (KE) Nru 1272/2008, kif emendat b’dan ir-Regolament, ma għandhomx japplikaw immedjatament, għaliex ikun meħtieġ ċertu perjodu ta’ żmien sabiex jippermetti lill-operaturi jadattaw l-ittikkettar u l-imballaġġ tas-sustanzi u t-taħlitiet għall-klassifikazzjonijiet il-ġodda u biex ibigħu l-istokkijiet eżistenti. Barra minn hekk, ikun meħtieġ ċertu perjodu ta’ żmien biex jippermetti lill-operaturi jikkonformaw mal-obbligi ta’ reġistrazzjoni li jirriżultaw mill-klassifikazzjonijiet armonizzati l-ġodda għal sustanzi kklassifikati bħala karċinoġeniċi, mutaġeniċi jew tossiċi għar-riproduzzjoni, il-kategoriji 1 A u 1B (Tabella 3.1) u l-kategoriji 1 u 2 (Tabella 3.2), jew bħala tossiċi ħafna għall-organiżmi akkwatiċi li jistgħu jikkawżaw effetti fit-tul fl-ambjent akkwatiku, b’mod partikolari b’dawk stipulati fl-Artikolu 23 tar-Regolament (KE) Nru 1907/2006 tal-Parlament Ewropew u tal-Kunsill tat-18 ta’ Diċembru 2006 dwar ir-Reġistrazzjoni, il-Valutazzjoni, l-Awtorizzazzjoni u r-Restrizzjoni ta’ Sustanzi Kimiċi (REACH), li jistabbilixxi Aġenzija Ewropea għas-Sustanzi Kimiċi, li jemenda d-Direttiva 1999/45/KE u li jħassar ir-Regolament tal-Kunsill (KEE) Nru 793/93 u r-Regolament tal-Kummissjoni (KE) Nru 1488/94 kif ukoll id-Direttiva tal-Kunsill 76/769/KEE u d-Direttivi tal-Kummissjoni 91/155/KEE, 93/67/KEE, 93/105/KE u 2000/21/KE (4) |
(5) |
Fir-rigward tas-sustanza żift, qatran tal-faħam, temp.-għolja (Numru KE: 266-028-2), perjodu estiż ta’ żmien se jkun neċessarju biex jippermetti lill-operaturi biex jikkonformaw mal-obbligazzjonijiet li jirriżultaw mill-klassifikazzjoni armonizzata ġdida għal sustanzi klassifikati bħala tossiċi ħafna għall-organiżmi akwatiċi li jistgħu jikkawżaw effetti fit-tul fl-ambjent akwatiku, b’mod partikolari b’dawk stipulati fl-Artikolu 3 u l-Anness III tad-Direttiva 2008/68/KE tal-Parlament Ewropew u tal-Kunsill tal-24 ta’ Settembru 2008 fuq-it-trasport intern ta’ oġġetti perikolużi (5). Għaldaqstant, żmien itwal ta’ tranżizzjoni għandu jiġi maħsub qabel il-klassifikazzjoni armonizzata tkun trid tiġi applikata. |
(6) |
Fir-rigward tas-sustanza arsenur tal-gallju (Numru KE: 215-114-8), ir-RAC (il-Kumitat għall-Istima tar-Riskji) jinsab fil-proċess li jadotta opinjoni ġdida għall-klassi ta’ periklu “tossiċità għar-riproduzzjoni”. Għaldaqstant, din il-klassi ta’ periklu m’għandhiex tiġi inkluża fl-Anness VI tar-Regolament (KE) Nru 1272/2008 sakemm dik l-opinjoni ma tkunx iffinalizzata. |
(7) |
Fir-rigward tas-sustanza idroklorur tal-polieżametalen bigwanur (numru CAS 27083-27-8 jew 32289-58-0), dejta xjentifika ġdida ġiet magħmula disponibbli għall-klassi ta’ periklu “tossiċità akuta (inalazzjoni)”, li tissuġġerixxi li l-klassifikazzjoni ta’ din il-klassi ta’ periklu kif rakkomandat fl-opinjoni tar-RAC, li hi bbażata fuq dejta eqdem, tista’ ma tkunx adatta. Għaldaqstant, din il-klassi ta’ periklu m’għandhiex tkun inkluża fl-Anness VI tar-Regolament (KE) Nru 1272/2008 sakemm ir-RAC ma jkunx ingħata l-opportunità li jwassal opinjoni dwar l-informazzjoni l-ġdida, waqt li klassijiet ta’ periklu oħra koperti mill-opinjoni iktar bikrija tar-RAC għandhom jiġu inklużi. |
(8) |
Skont id-dispożizzjonijiet tranżizzjonali tar-Regolament (KE) Nru 1272/2008 li jippermettu l-applikazzjoni tad-dispożizzjonijiet il-ġodda fi stadju aktar bikri fuq bażi volontarja, il-fornituri għandom ikollhom il-possibilità li japplikaw il-klassifikazzjoni armonizzata stipulata fil-Parti 3 tal-Anness VI għar-Regolament (KE) Nru 1272/2008, kif emendat permezz ta’ dan ir-Regolament, u li għalhekk jadattaw l-ittikkettar u l-imballaġġ fuq bażi volontarja qabel id-dati sa meta il-klassifikazzjoni armonizzata se ssir obbligatorja. |
(9) |
Il-miżuri stabbiliti f’dan ir-Regolament huma skont l-opinjoni tal-Kumitat stabbilit bl-Artikolu 133 tar-Regolament (KE) Nru 1907/2006, |
ADOTTAT DAN IR-REGOLAMENT:
Artikolu 1
Ir-Regolament (KE) Nru 1272/2008 huwa emendat kif ġej:
(1) |
L-Anness IV huwa emendat skont l-Anness I ta’ dan ir-Regolament; |
(2) |
Il-parti 3 tal-Anness VI hija emendata kif ġej:
|
Artikolu 2
1. Permezz ta’ deroga mit-tieni paragrafu tal-Artikolu 3(2), is-sustanzi u t-taħlitiet jistgħu, qabel l-1 ta’ Diċembru 2014 u l-1 ta’ Ġunju 2015 rispettivament, jiġu kklassifikati, ittikkettjati u ppakkjati skont ir-Regolament (KE) Nru 1272/2008 kif emendat b’dan ir-Regolament.
2. B’deroga mit-tieni paragrafu tal-Artikolu 3(2), is-sustanzi kklassifikati, ittikkettjati u ppakkjati skont ir-Regolament (KE) Nru 1272/2008 u mqiegħda fis-suq qabel l-1 ta’ Diċembru 2014, ma għandhomx jintalbu li jerġgħu jiġu ttikkettjati u ppakkjati skont ir-Regolament (KE) Nru 1272/2008 kif emendat permezz ta’ dan ir-Regolament sal-1 ta’ Diċembru 2016.
3. B’deroga mit-tieni paragrafu tal-Artikolu 3(2) it-taħlitiet kklassifikati, ittikkettjati u mmballaġġati skont id-Direttiva 1999/45/KE tal-Parlament Ewropew u tal-Kunsill (6) jew ir-Regolament (KE) Nru 1272/2008 u mqiegħda fis-suq qabel l-1 ta’ Ġunju 2015, ma għandhomx jintalbu li jerġgħu jiġu ttikkettjati u mmballaġġati skont ir-Regolament (KE) Nru 1272/2008 kif emendat permezz ta’ dan ir-Regolament sal-1 ta’ Ġunju 2017.
4. Permezz tad-deroga mill-Artikolu 3(3) il-klassifikazzjoni armonizzata stipulata f’Parti 3 tal-Anness VI tar-Regolament (KE) Nru 1272/2008, kif emendat permezz ta’ dan ir-Regolament, jista’ jiġi applikat qabel id-dati msemmija fl-Artikolu 3(3).
Artikolu 3
1. Dan ir-Regolament għandu jidħol fis-seħħ fl-għoxrin jum ta’ wara l-pubblikazzjoni tiegħu f’Il-Ġurnal Uffiċjali tal-Unjoni Ewropea.
2. L-Artikolu 1(1) għandu japplika fir-rigward ta’ sustanzi mill-1 ta’ Diċembru 2014 u fir-rigward ta’ taħlitiet mill-1 ta’ Ġunju 2015.
3. L-Artikolu 1(2) għandu japplika mill-1 ta’ Jannar 2015 għall-entrati kollha ħlief għall-entrata żift, qatran tal-faħam, temp.-għolja (Numru KE 266-028-2), li għalihom l-Artikolu 1 għandu japplika mill-1 ta’ April 2016.
Dan ir-Regolament għandu jorbot fl-intier tiegħu u japplika direttament fl-Istati Membri kollha.
Magħmul fi Brussell, it-2 ta’ Ottubru 2013.
Għall-Kummissjoni
Il-President
José Manuel BARROSO
(1) ĠU L 353, 31.12.2008, p. 1.
(4) ĠU L 396, 30.12.2006, p. 1.
(5) ĠU L 260, 30.9.2008, p. 13.
(6) ĠU L 200, 30.7.1999, p. 1.
ANNESS I
F’Parti 1, Tabella 6.2 tal-Anness IV tar-Regolament (KE) Nru 1272/2008 il-Kodiċi P210 jinbidel b’dan li ġej:
“P210 |
Żomm ’il bogħod mis-sħana, uċuħ jaħarqu, xrar tan-nar, fjammi miftuħa u sorsi oħra li jaqbdu. Tpejjipx. |
Splussivi (it-Taqsima 2.1) |
Id-diviżjonijiet 1.1, 1.2, 1.3, 1.4, 1.5 |
|
Gassijiet li jaqbdu (it-Taqsima 2.2) |
1, 2 |
|||
Ajrusoli (it-Taqsima 2.3) |
1, 2, 3 |
|||
Likwidi li jaqbdu (it-Taqsima 2.6) |
1, 2, 3 |
|||
Solidi li jaqbdu (it-Taqsima 2.7) |
1, 2 |
|||
Sustanzi u taħlitiet awtoreattivi (it-Taqsima 2.8) |
Tipi A, B, C, D, E, F |
|||
Likwidi piroforiċi (it-Taqsima 2.9) |
1 |
|||
Solidi piroforiċi (it-Taqsima 2.10) |
1 |
|||
Likwidi ossidanti (it-Taqsima 2.13) |
1, 2, 3 |
|||
Solidi ossidanti (it-Taqsima 2.14) |
1, 2, 3 |
|||
Perossidi organiċi (it-Taqsima 2.15) |
Tipi A, B, C, D, E, F” |
ANNESS II
Nru tal-Indiċi |
Identifikazzjoni Kimika Internazzjonali |
Nru tal-KE |
Nru tal-CAS |
Klassifikazzjoni |
Tikkettar |
Limiti ta’ konċentrazzjonijiet speċifiċi, M - Fatturi |
Noti |
|||||||||||||||||||||||||||||||||||||||||
Klassi tal-Periklu u Kodiċi(jiet) tal-Kategorija |
Kodiċi(jiet) ta’ dikjarazzjoni tal-Periklu |
Pittogramma, Kodiċi(jiet) tal-Kelma Sinjal |
Kodiċi(jiet) ta’ Dikjarazzjoni tal-Periklu |
Kodiċi(jiet) supplimentari ta’ Dikjarazzjoni tal-Periklu |
||||||||||||||||||||||||||||||||||||||||||||
015-004-00-8 |
aluminium phosphide |
244-088-0 |
20859-73-8 |
Water-react. 1 |
H260 |
GHS02 |
H260 |
EUH029 |
M = 100 |
|
||||||||||||||||||||||||||||||||||||||
Acute Tox. 2 |
H300 |
GHS06 |
H300 |
EUH032 |
|
|||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 3 |
H311 |
GHS09 |
H311 |
|
||||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 1 |
H330 |
Dgr |
H330 |
|
||||||||||||||||||||||||||||||||||||||||||||
Aquatic Acute 1 |
H400 |
|
H400 |
|
||||||||||||||||||||||||||||||||||||||||||||
015-005-00-3 |
magnesium phosphide; trimagnesium diphosphide |
235-023-7 |
12057-74-8 |
Water-react. 1 |
H260 |
GHS02 |
H260 |
EUH029 |
M = 100 |
|
||||||||||||||||||||||||||||||||||||||
Acute Tox. 2 |
H300 |
GHS06 |
H300 |
EUH032 |
|
|||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 3 |
H311 |
GHS09 |
H311 |
|
||||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 1 |
H330 |
Dgr |
H330 |
|
||||||||||||||||||||||||||||||||||||||||||||
Aquatic Acute 1 |
H400 |
|
H400 |
|
||||||||||||||||||||||||||||||||||||||||||||
015-123-00-5 |
fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate |
244-848-1 |
22224-92-6 |
Acute Tox. 2 |
H300 |
GHS06 |
H300 |
|
M = 100 M = 100 |
|
||||||||||||||||||||||||||||||||||||||
Acute Tox. 2 |
H310 |
GHS09 |
H310 |
|||||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 2 |
H330 |
Dgr |
H330 |
|||||||||||||||||||||||||||||||||||||||||||||
Eye Irrit. 2 |
H319 |
|
H319 |
|||||||||||||||||||||||||||||||||||||||||||||
Aquatic Acute 1 |
H400 |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||||||||||||||||||||||||||||||||||||||||
030-012-00-1 |
aluminium-magnesium-zinc-carbonate-hydroxide |
423-570-6 |
169314-88-9 |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
||||||||||||||||||||||||||||||||||||||
602-006-00-4 |
chloroform; trichloromethane |
200-663-8 |
67-66-3 |
Carc. 2 |
H351 |
GHS06 |
H351 |
|
|
|
||||||||||||||||||||||||||||||||||||||
Repr. 2 |
H361d |
GHS08 |
H361d |
|||||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 3 |
H331 |
Dgr |
H331 |
|||||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 4 |
H302 |
|
H302 |
|||||||||||||||||||||||||||||||||||||||||||||
STOT RE 1 |
H372 |
|
H372 |
|||||||||||||||||||||||||||||||||||||||||||||
Eye Irrit. 2 |
H319 |
|
H319 |
|||||||||||||||||||||||||||||||||||||||||||||
Skin Irrit. 2 |
H315 |
|
H315 |
|||||||||||||||||||||||||||||||||||||||||||||
603-097-00-3 |
1,1’,1”-nitrilotripropan-2-ol; triisopropanolamine |
204-528-4 |
122-20-3 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
||||||||||||||||||||||||||||||||||||||
605-008-00-3 |
acrolein; prop-2-enal; acrylaldehyde |
203-453-4 |
107-02-8 |
Flam. Liq. 2 |
H225 |
GHS02 |
H225 |
EUH071 |
Skin Corr. 1; H314: C ≥ 0,1 % |
D |
||||||||||||||||||||||||||||||||||||||
Acute Tox. 1 |
H330 |
GHS06 |
H330 |
|
||||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 2 |
H300 |
GHS05 |
H300 |
|
||||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 3 |
H311 |
GHS09 |
H311 |
|
||||||||||||||||||||||||||||||||||||||||||||
Skin Corr. 1 |
H314 |
Dgr |
H314 |
|
||||||||||||||||||||||||||||||||||||||||||||
Aquatic Acute 1 |
H400 |
|
|
|
M = 100 |
|||||||||||||||||||||||||||||||||||||||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|
M = 1 |
|||||||||||||||||||||||||||||||||||||||||||
607-023-00-0 |
vinyl acetate |
203-545-4 |
108-05-4 |
Flam. Liq. 2 |
H225 |
GHS02 |
H225 |
|
|
D |
||||||||||||||||||||||||||||||||||||||
Carc. 2 |
H351 |
GHS08 |
H351 |
|
|
|||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 4 |
H332 |
GHS07 |
H332 |
|
|
|||||||||||||||||||||||||||||||||||||||||||
STOT SE 3 |
H335 |
Dgr |
H335 |
|
|
|||||||||||||||||||||||||||||||||||||||||||
607-613-00-8 |
reaction mass of:
|
432-790-1 |
|
Acute Tox. 4* |
H332 |
GHS07 |
H332 |
|
|
|
||||||||||||||||||||||||||||||||||||||
Acute Tox. 4* |
H312 |
GHS05 |
H312 |
|||||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 4* |
H302 |
GHS08 |
H302 |
|||||||||||||||||||||||||||||||||||||||||||||
Skin Corr. 1B |
H314 |
Dgr |
H314 |
|||||||||||||||||||||||||||||||||||||||||||||
STOT SE 2 |
H371 (għajnejn) |
|
H371 (għajnejn) |
|||||||||||||||||||||||||||||||||||||||||||||
609-003-00-7 |
nitrobenzene |
202-716-0 |
98-95-3 |
Carc. 2. |
H351 |
GHS06 |
H351 |
|
|
|
||||||||||||||||||||||||||||||||||||||
Repr. 1B |
H360F |
GHS08 |
H360F |
|||||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 3 |
H301 |
Dgr |
H301 |
|||||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 3 |
H331 |
|
H331 |
|||||||||||||||||||||||||||||||||||||||||||||
Acute Tox. 3 |
H311 |
|
H311 |
|||||||||||||||||||||||||||||||||||||||||||||
STOT RE 1 |
H372 (demm) |
|
H372 (demm) |
|||||||||||||||||||||||||||||||||||||||||||||
Aquatic Chronic 3 |
H412 |
|
H412 |
|||||||||||||||||||||||||||||||||||||||||||||
612-120-00-6 |
aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline |
277-704-1 |
74070-46-5 |
Carc. 2 |
H351 |
GHS08 |
H351 |
|
M = 100 M = 10 |
|
||||||||||||||||||||||||||||||||||||||
Skin Sens. 1 A |
H317 |
GHS07 |
H317 |
|
||||||||||||||||||||||||||||||||||||||||||||
Aquatic Acute 1 |
H400 |
GHS09 |
|
|
||||||||||||||||||||||||||||||||||||||||||||
Aquatic Chronic 1 |
H410 |
Wng |
H410 |
|
||||||||||||||||||||||||||||||||||||||||||||
613-175-00-9 |
epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[( 1H-1,2,4-triazol-1-yl)methyl]oxirane |
406-850-2 |
133855-98-8 |
Carc. 2 |
H351 |
GHS08 |
H351 |
|
|
|
||||||||||||||||||||||||||||||||||||||
Repr. 1B |
H360Df |
GHS09 |
H360Df |
|||||||||||||||||||||||||||||||||||||||||||||
Aquatic Chronic 2 |
H411 |
Dgr |
H411 |
|||||||||||||||||||||||||||||||||||||||||||||
616-200-00-1 |
reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide) |
432-430-3 |
|
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
||||||||||||||||||||||||||||||||||||||
648-055-00-5 |
pitch, coal tar, high-temp.; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] |
266-028-2 |
65996-93-2 |
Carc. 1 A |
H350 |
GHS08 |
H350 |
|
M = 1000 M = 1000 |
|
||||||||||||||||||||||||||||||||||||||
Muta. 1B |
H340 |
GHS09 |
H340 |
|
||||||||||||||||||||||||||||||||||||||||||||
Repr. 1B |
H360FD |
Dgr |
H360FD |
|
||||||||||||||||||||||||||||||||||||||||||||
Aquatic Acute 1 |
H400 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|
||||||||||||||||||||||||||||||||||||||||||||
649-330-00-2 |
naphtha (petroleum), hydrodesulphurized heavy; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).] |
265-185-4 |
64742-82-1 |
Carc. 1B |
H350 |
GHS08 |
H350 |
|
|
P |
||||||||||||||||||||||||||||||||||||||
Muta. 1B |
H340 |
Dgr |
H340 |
|||||||||||||||||||||||||||||||||||||||||||||
STOT RE 1 |
H372 (sistema nervuża ċentrali) |
|
H372 (sistema nervuża ċentrali) |
|||||||||||||||||||||||||||||||||||||||||||||
Asp. Tox. 1 |
H304 |
|
H304 |
|||||||||||||||||||||||||||||||||||||||||||||
649-345-00-4 |
stoddard solvent; Low boiling point naphtha — unspecified; [A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).] |
232-489-3 |
8052-41-3 |
Carc. 1B |
H350 |
GHS08 |
H350 |
|
|
P |
||||||||||||||||||||||||||||||||||||||
Muta. 1B |
H340 |
Dgr |
H340 |
|||||||||||||||||||||||||||||||||||||||||||||
STOT RE 1 |
H372 (sistema nervuża ċentrali) |
|
H372 (sistema nervuża ċentrali) |
|||||||||||||||||||||||||||||||||||||||||||||
Asp. Tox. 1 |
H304 |
|
H304 |
|||||||||||||||||||||||||||||||||||||||||||||
649-405-00-X |
solvent naphtha (petroleum), medium aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).] |
265-191-7 |
64742-88-7 |
STOT RE 1 |
H372 (sistema nervuża ċentrali) |
GHS08 |
H372 (sistema nervuża ċentrali) |
|
|
|
||||||||||||||||||||||||||||||||||||||
Asp. Tox. 1 |
H304 |
Dgr |
H304 |
ANNESS III
Nru tal-Indiċi |
Identifikazzjoni Kimika Internazzjonali |
Nru tal-KE |
Nru tal-CAS |
Klassifikazzjoni |
Tikkettar |
Limiti ta’ konċentrazzjonijiet speċifiċi, M - Fatturi |
Noti |
|||
Klassi tal-Periklu u Kodiċi(jiet) tal-Kategorija |
Kodiċi(jiet) ta’ Dikjarazzjoni tal-Periklu |
Pittogramma, Kodiċi(jiet) tal-Kelma Sinjal |
Kodiċi(jiet) ta’ Dikjarazzjoni tal-Periklu |
Kodiċi(jiet) supplimentari ta’ Dikjarazzjoni tal-Periklu |
||||||
031-001-00-4 |
gallium arsenide |
215-114-8 |
1303-00-0 |
Carc. 1B |
H350 |
GHS08 |
H350 |
|
|
|
STOT RE 1 |
H372 (sistemi respiratorji u emopojetiċi) |
Dgr |
H372 (sistemi respiratorji u emopojetiċi) |
|||||||
050-025-00-6 |
trichloromethylstannane |
213-608-8 |
993-16-8 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
050-026-00-1 |
2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate |
260-828-5 |
57583-34-3 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
050-027-00-7 |
2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate |
239-622-4 |
15571-58-1 |
Repr. 1B |
H360D |
GHS08 Dgr |
H360D |
|
|
|
601-087-00-3 |
2,4,4-trimethylpentene |
246-690-9 |
25167-70-8 |
Flam. Liq. 2 |
H225 |
GHS02 |
H225 |
|
|
D |
Asp. Tox. 1 |
H304 |
GHS07 |
H304 |
|||||||
STOT SE 3 |
H336 |
GHS08 Dgr |
H336 |
|||||||
606-145-00-1 |
sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione |
|
99105-77-8 |
Repr. 2 |
H361d |
GHS08 |
H361d |
|
M = 1 M = 10 |
|
STOT RE 2 |
H373 (kliewi) |
GHS07 |
H373 (kliewi) |
|||||||
Skin Sens. 1 A |
H317 |
GHS09 |
H317 |
|||||||
Aquatic Acute 1 |
H400 |
Wng |
|
|||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||
607-699-00-7 |
bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate |
|
82657-04-3 |
Carc. 2 |
H351 |
GHS06 |
H351 |
|
M = 10 000 M = 100 000 |
|
Acute Tox. 3 |
H331 |
GHS08 |
H331 |
|||||||
Acute Tox. 2 |
H300 |
GHS09 |
H300 |
|||||||
STOT RE 1 |
H372 (sistema nervuża) |
Dgr |
H372 (sistema nervuża) |
|||||||
Skin Sens. 1B |
H317 |
|
H317 |
|||||||
Aquatic Acute 1 |
H400 |
|
|
|||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||
607-700-00-0 |
indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1] |
|
173584-44-6 [1] |
Acute Tox. 3 |
H301 |
GHS06 |
H301 |
|
M = 1 M = 1 |
|
Acute Tox. 4 |
H332 |
GHS08 |
H332 |
|||||||
STOT RE 1 |
H372 (demm, sistema nervuża, qalb) |
GHS09 |
H372 (demm, sistema nervuża, qalb) |
|||||||
Skin Sens. 1B |
H317 |
Dgr |
H317 |
|||||||
Aquatic Acute 1 |
H400 |
|
|
|||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||
reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2] |
144171-61-9 [2] |
|
|
|
|
|||||
607-702-00-1 |
dihexyl phthalate |
201-559-5 |
84-75-3 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
607-703-00-7 |
ammoniumpentadeca- fluorooctanoate |
223-320-4 |
3825-26-1 |
Carc. 2 |
H351 |
GHS08 |
H351 |
|
|
|
Repr. 1B |
H360D |
GHS07 |
H360D |
|||||||
Lact. |
H362 |
GHS05 |
H362 |
|||||||
Acute Tox. 4 |
H332 |
Dgr |
H332 |
|||||||
Acute Tox. 4 |
H302 |
|
H302 |
|||||||
STOT RE 1 |
H372 (fwied) |
|
H372 (fwied) |
|||||||
Eye Dam.1 |
H318 |
|
H318 |
|||||||
607-704-00-2 |
perfluorooctanoic acid |
206-397-9 |
335-67-1 |
Carc. 2 |
H351 |
GHS08 |
H351 |
|
|
|
Repr. 1B |
H360D |
GHS07 |
H360D |
|||||||
Lact. |
H362 |
GHS05 |
H362 |
|||||||
Acute Tox. 4 |
H332 |
Dgr |
H332 |
|||||||
Acute Tox. 4 |
H302 |
|
H302 |
|||||||
STOT RE 1 |
H372 (fwied) |
|
H372 (fwied) |
|||||||
Eye Dam. 1 |
H318 |
|
H318 |
|||||||
612-282-00-8 |
octadecylamine |
204-695-3 |
124-30-1 |
Asp. Tox. 1 |
H304 |
GHS05 |
H304 |
|
M = 10 M = 10 |
|
STOT RE 2 |
H373 (passaġġ gastrointestinali, fwied, sistema immunitarja) |
GHS08 |
H373 (passaġġ gastrointestinali, fwied, sistema immunitarja) |
|||||||
Skin Irrit. 2 |
H315 |
GHS09 |
H315 |
|||||||
Eye Dam. 1 |
H318 |
Dgr |
H318 |
|||||||
Aquatic Acute 1 |
H400 |
|
|
|||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||
612-283-00-3 |
(Z)-octadec-9-enylamine |
204-015-5 |
112-90-3 |
Acute Tox. 4 |
H302 |
GHS05 |
H302 |
|
M = 10 M = 10 |
|
Asp Tox. 1 |
H304 |
GHS07 |
H304 |
|||||||
STOT SE 3 |
H335 |
GHS08 |
H335 |
|||||||
STOT RE 2 |
H373 (passaġġ gastrointestinali, fwied, sistema immunitarja) |
GHS09 |
H373 (passaġġ gastrointestinali, fwied, sistema immunitarja) |
|||||||
Skin Corr. 1B |
H314 |
Dgr |
H314 |
|||||||
Aquatic Acute 1 |
H400 |
|
|
|||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||
612-284-00-9 |
amines, hydrogenated tallow alkyl |
262-976-6 |
61788-45-2 |
Asp Tox. 1 |
H304 |
GHS08 |
H304 |
|
M = 10 M = 10 |
|
STOT RE 2 |
H373 (passaġġ gastrointestinali, fwied, sistema immunitarja) |
GHS05 |
H373 (passaġġ gastrointestinali, fwied, sistema immunitarja) |
|||||||
Skin Irrit. 2 |
H315 |
GHS09 |
H315 |
|||||||
Eye Dam. 1 |
H318 |
Dgr |
H318 |
|||||||
Aquatic Acute 1 |
H400 |
|
|
|||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||
612-285-00-4 |
amines, coco alkyl |
262-977-1 |
61788-46-3 |
Acute Tox. 4 |
H302 |
GHS05 |
H302 |
|
M = 10 M = 10 |
|
Asp. Tox. 1 |
H304 |
GHS07 |
H304 |
|||||||
STOT SE 3 |
H335 |
GHS08 |
H335 |
|||||||
STOT RE 2 |
H373 (passaġġ gastrointestinali, fwied, sistema immunitarja) |
GHS09 |
H373 (passaġġ gastrointestinali, fwied, sistema immunitarja) |
|||||||
Skin Corr. 1B |
H314 |
Dgr |
H314 |
|||||||
Aquatic Acute 1 |
H400 |
|
|
|||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||
612-286-00-X |
amines, tallow alkyl |
263-125-1 |
61790-33-8 |
Acute Tox. 4 |
H302 |
GHS05 |
H302 |
|
M = 10 M = 10 |
|
Asp. Tox. 1 |
H304 |
GHS07 |
H304 |
|||||||
STOT RE 2 |
H373 (passaġġ gastrointestinali, fwied, sistema immunitarja) |
GHS08 |
H373 (passaġġ gastrointestinali, fwied, sistema immunitarja) |
|||||||
Skin Corr. 1B |
H314 |
GHS09 |
H314 |
|||||||
Aquatic Acute 1 |
H400 |
Dgr |
|
|||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||
616-206-00-4 |
flufenoxuron (ISO); 1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea |
417-680-3 |
101463-69-8 |
Lact. |
H362 |
GHS09 |
H362 |
|
M = 10 000 M = 10 000 |
|
Aquatic Acute 1 |
H400 |
Wng |
|
|||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||
616-207-00-X |
polyhexamethylene biguanide hydrochloride |
|
27083-27-8 or 32289-58-0 |
Carc. 2 |
H351 |
GHS05 |
H351 |
|
M = 10 M = 10 |
|
Acute Tox. 4 |
H302 |
GHS07 |
H302 |
|||||||
STOT RE 1 |
H372 (passaġġ respiratorju) (nifs ‘il ġewwa) |
GHS08 |
H372 (passaġġ respiratorju) (nifs ‘il ġewwa) |
|||||||
Eye Dam. 1 |
H318 |
GHS09 |
H318 |
|||||||
Skin Sens. 1B |
H317 |
Dgr |
H317 |
|||||||
Aquatic Acute 1 |
H400 |
|
|
|||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||
616-208-00-5 |
N-ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one |
220-250-6 |
2687-91-4 |
Repr. 1B |
H360D |
GHS08 Dgr |
H360D |
|
|
|
616-209-00-0 |
amidosulfuron (ISO); 3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea |
407-380-0 |
120923-37-7 |
Aquatic Acute 1 |
H400 |
GHS09 |
|
|
M = 100 M = 100 |
|
Aquatic Chronic 1 |
H410 |
Wng |
H410 |
|||||||
616-210-00-6 |
tebufenpyrad (ISO); N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide |
|
119168-77-3 |
Acute Tox. 3 |
H301 |
GHS06 |
H301 |
|
M = 10 M = 10 |
|
Acute Tox. 4 |
H332 |
GHS08 |
H332 |
|||||||
STOT RE 2 |
H373 (passaġġ gastrointestinali) (Orali) |
GHS09 |
H373 (passaġġ gastrointestinali) (Orali) |
|||||||
Skin Sens. 1B |
H317 |
Dgr |
H317 |
|||||||
Aquatic Acute 1 |
H400 |
|
|
|||||||
Aquatic Chronic 1 |
H410 |
|
H410 |
|||||||
616-211-00-1 |
proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one |
|
189278-12-4 |
Carc. 2 |
H351 |
GHS08 |
H351 |
|
M = 1 M = 10 |
|
Aquatic Acute 1 |
H400 |
GHS09 |
|
|||||||
Aquatic Chronic 1 |
H410 |
Wng |
H410 |
ANNESS IV
Nru tal-Indiċi |
Identifikazzjoni Kimika Internazzjonali |
Nru tal-KE |
Nru tal-CAS |
Klassifikazzjoni |
Tikkettar |
Limiti tal-Konċentrazzjoni |
Noti |
||||||||||||||||||||||||||||||||||||||||||
015-004-00-8 |
aluminium phosphide |
244-088-0 |
20859-73-8 |
F; R15/29 T+; R26/28 Xn; R21 R32 N; R50 |
F; T+; N R: 15/29-21- 26/28-32-50 S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61 |
N; R50: C ≥ 0,25 % |
|
||||||||||||||||||||||||||||||||||||||||||
015-005-00-3 |
magnesium phosphide; trimagnesium diphosphide |
235-023-7 |
12057-74-8 |
F; R15/29 T+; R26/28 Xn; R21 R32 N; R50 |
F; T+; N R: 15/29-21-26/28-32-50 S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61 |
N; R50: C ≥ 0,25 % |
|
||||||||||||||||||||||||||||||||||||||||||
015-123-00-5 |
fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate |
244-848-1 |
22224-92-6 |
T+; R26/28 T; R24 Xi; R36 N; R50-53 |
T+; N R: 24-26/28-36-50/53 S: (1/2-)23-26-28-35-36/37-45-60-61 |
N; R50-53: C ≥ 0,25 % N; R51-53: 0,025 % ≤ C < 0,25 % R52-53: 0,0025 % ≤ C < 0,025 % |
|
||||||||||||||||||||||||||||||||||||||||||
030-012-00-1 |
aluminium-magnesium-zinc-carbonate-hydroxide |
423-570-6 |
169314-88-9 |
R53 |
R: 53 S: 61 |
|
|
||||||||||||||||||||||||||||||||||||||||||
602-006-00-4 |
chloroform; trichloromethane |
200-663-8 |
67-66-3 |
Carc. Cat. 3; R40 Repr. Cat. 3; R63 Xn; R20/22-48/20 Xi; R36/38 |
Xn R: 20/22-36/38-40-48/20-63 S: (2-)36/37 |
|
|
||||||||||||||||||||||||||||||||||||||||||
603-097-00-3 |
1,1′,1′′-nitrilotripropan-2-ol; triisopropanolamine |
204-528-4 |
122-20-3 |
Xi; R36 |
Xi R: 36 S: (2-)26 |
|
|
||||||||||||||||||||||||||||||||||||||||||
605-008-00-3 |
acrolein; prop-2-enal; acrylaldehyde |
203-453-4 |
107-02-8 |
F; R11 T+; R26/28 T; R24 C; R34 N; R50 |
F; T+; N R: 11-24-26/28-34-50 S: (1/2-)23-26-28-36/37/39-45-61 |
C; R34: C ≥ 0,1 % N; R50: C ≥ 0,25 % |
D |
||||||||||||||||||||||||||||||||||||||||||
607-023-00-0 |
vinyl acetate |
203-545-4 |
108-05-4 |
F; R11 Carc. Cat. 3; R40 Xn; R20 Xi; R37 |
F; Xn R: 11-20-37-40 S: 9-16-33-36/37 |
|
D |
||||||||||||||||||||||||||||||||||||||||||
607-613-00-8 |
reaction mass of:
|
432-790-1 |
|
C; R34 Xn; R20/21/22-68/20/21/22 |
C R: 20/21/22-34-68/20/21/22 S: (1/2-)26-28-36/37/39-45 |
|
|
||||||||||||||||||||||||||||||||||||||||||
609-003-00-7 |
nitrobenzene |
202-716-0 |
98-95-3 |
Carc. Cat. 3; R40 Repr. Cat. 2; R60 T; R23/24/25-48/23/24/25 R52-53 |
T R: 23/24/25-48/23/24/25-40-60-52/53 S: 45-53 |
|
|
||||||||||||||||||||||||||||||||||||||||||
612-120-00-6 |
aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline |
277-704-1 |
74070-46-5 |
Carc. Cat. 3; R40 R43 N; R50-53 |
Xn; N R: 40-43-50/53 S: (2-)36/37-60-61 |
R43: C ≥ 0,1 % N; R50-53: C ≥ 0,25 % N; R51-53: 0,025 % ≤ C < 0,25 % R52-53: 0,0025 % ≤ C < 0,025 % |
|
||||||||||||||||||||||||||||||||||||||||||
613-175-00-9 |
epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane |
406-850-2 |
133855-98-8 |
Carc. Cat. 3; R40 Repr. Cat. 2; R61 Repr. Cat. 3; R62 N; R51-53 |
T; N R: 61-40-62-51/53 S: 45-53-61 |
|
|
||||||||||||||||||||||||||||||||||||||||||
616-200-00-1 |
reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide) |
432-430-3 |
|
R53 |
R: 53 S: 61 |
|
|
||||||||||||||||||||||||||||||||||||||||||
648-055-00-5 |
pitch, coal tar, high-temp.; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] |
266-028-2 |
65996-93-2 |
Carc. Cat. 1; R45 Muta. Cat. 2; R46 Repr. Cat. 2; R60-61 N; R50-53 |
T; N R: 45-46-60-61-50/53 S: 45-53-60-61 |
N; R50-53: C ≥ 0,025 % N; R51-53: 0,0025 % ≤ C < 0,025 % R52-53: 0,00025 % ≤ C < 0,0025 % |
|
||||||||||||||||||||||||||||||||||||||||||
649-330-00-2 |
naphtha (petroleum), hydrodesulphurized heavy; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).] |
265-185-4 |
64742-82-1 |
Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R48/20-65 |
T R: 45-46-48/20-65 S: 45-53 |
|
P |
||||||||||||||||||||||||||||||||||||||||||
649-345-00-4 |
stoddard solvent; Low boiling point naphtha — unspecified; [A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).] |
232-489-3 |
8052-41-3 |
Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R48/20-65 |
T R: 45-46-48/20-65 S: 45-53 |
|
P |
||||||||||||||||||||||||||||||||||||||||||
649-405-00-X |
solvent naphtha (petroleum), medium aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).] |
265-191-7 |
64742-88-7 |
Xn; R48/20-65 |
Xn R: 48/20-65 S: (2-)23-24-62 |
|
|
ANNESS V
Nru tal-Indiċi |
Identifikazzjoni Kimika Internazzjonali |
Nru tal-KE |
Nru tal-CAS |
Klassifikazzjoni |
Tikkettar |
Limiti tal-Konċentrazzjoni |
Noti |
031-001-00-4 |
gallium arsenide |
215-114-8 |
1303-00-0 |
Carc. Cat. 2; R45 T; R48/23 |
T R: 45-48/23 S: 45-53 |
|
E |
050-025-00-6 |
trichloromethylstannane |
213-608-8 |
993-16-8 |
Repr. Cat. 3; R63 |
Xn R: 63 S: (2-)22-36/37 |
|
|
050-026-00-1 |
2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate |
260-828-5 |
57583-34-3 |
Repr. Cat. 3; R63 |
Xn R: 63 S: (2-)22-36/37 |
|
|
050-027-00-7 |
2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate |
239-622-4 |
15571-58-1 |
Repr. Cat. 2; R61 |
T R: 61 S: 45-53 |
|
|
601-087-00-3 |
2,4,4-trimethylpentene |
246-690-9 |
25167-70-8 |
F; R11 Xn; R65 R67 |
F; Xn R: 11-65-67 S: 9-16-33-62 |
|
D |
606-145-00-1 |
sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione |
|
99105-77-8 |
Repr. Cat. 3; R63 Xn; R48/22 R43 N; R50-53 |
Xn; N R: 43-48/22-63-50/53 S: (2-)22-36/37-60-61 |
N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C< 2,5 % R43: C ≥ 0,1 % |
|
607-699-00-7 |
bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate |
|
82657-04-3 |
Carc. Cat 3; R40 T; R23/25 Xn; R48/22 R43 N; R50-53 |
T; N R: 23/25-40-43-48/22-50/53 S: (1/2-)23-24-36/37-38- 45-60-61 |
N; R50-53: C ≥ 0,0025 % N; R51-53: 0,00025 % ≤ C< 0,0025 % R52-53: 0,000025 % ≤ C < 0,00025 % |
|
607-700-00-0 |
indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate |
|
173584-44-6 |
T; R25-48/25 Xn; R20 R43 N; R50-53 |
T; N R: 20-25-43-48/25-50/53 S: (1/2-)24-37-45-60-61 |
N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 % |
|
607-701-00-6 |
reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate |
|
144171-61-9 |
T; R48/25 Xn; R20/22 R43 N; R50-53 |
T; N R: 20/22-43-48/25-50/53 S: (1/2-)24-37-45-60-61 |
N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 % |
|
607-702-00-1 |
dihexyl phthalate |
201-559-5 |
84-75-3 |
Repr. Cat. 2; R60-61 |
T R: 60-61 S: 45-53 |
|
|
607-703-00-7 |
ammoniumpentade- cafluorooctanoate |
223-320-4 |
3825-26-1 |
Carc. Cat. 3; R40 Repr. Cat. 2; R61 R64 T; R48/23 Xn; R20/22-48/21/22 Xi; R41 |
T R: 61-20/22-40-41- 48/23-48/21/22-64 S: 45-53 |
|
|
607-704-00-2 |
perfluorooctanoic acid |
206-397-9 |
335-67-1 |
Carc. Cat. 3; R40 Repr. Cat. 2; R61 R64 T; R48/23 Xn; R20/22-48/21/22 Xi; R41 |
T R: 61-20/22-40-41-48/23-48/21/22-64 S: 45-53 |
|
|
612-282-00-8 |
octadecylamine |
204-695-3 |
124-30-1 |
Xn; R48/22-65 Xi; R38-41 N; R50-53 |
Xn; N R: 38-41-48/22-65-50/53 S: (2-)26-36/37/39-60-61-62 |
N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 % |
|
612-283-00-3 |
(Z)-octadec-9-enylamine |
204-015-5 |
112-90-3 |
Xn; R22-48/22-65 C; R34 N; R50-53 |
C; N R: 22-34-48/22-65-50/53 S: (1/2-)23-26-36/37/39-45-60-61-62 |
C; R34: C ≥ 10 % Xi; R36/37/38: 5 % ≤ C < 10 % N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 % |
|
612-284-00-9 |
amines, hydrogenated tallow alkyl |
262-976-6 |
61788-45-2 |
Xn; R48/22-65 Xi; R38-41 N; R50-53 |
Xn; N R: 38-41-48/22-65-50/53 S: (2-)26-36/37/39-60-61-62 |
N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 % |
|
612-285-00-4 |
amines, coco alkyl |
262-977-1 |
61788-46-3 |
Xn; R22-48/22-65 C; R35 N; R50-53 |
C; N R: 22-35-48/22-65-50/53 S: (1/2-)23-26-36/37/39-45-60-61-62 |
C; R35: C ≥ 10 % C; R34: 5 % ≤ C < 10 % Xi; R36/37/38: 1 % ≤ C < 5 % N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 % |
|
612-286-00-X |
amines, tallow alkyl |
263-125-1 |
61790-33-8 |
Xn; R22-48/22-65 C; R35 N; 50-53 |
C; N R: 22-35-48/22-65-50/53 S: (1/2-)26-36/37/39-45-60-61-62 |
N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 % |
|
616-206-00-4 |
flufenoxuron (ISO); 1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea |
417-680-3 |
101463-69-8 |
R64 R33 N; R50-53 |
N R: 33-64-50/53 S: (2-)22-36/37-46-60-61 |
N; R50-53 C > 0,0025 % N; R51-53 0,00025 % < C < 0,0025 % R52-53 0,000025 % < C < 0,00025 % |
|
616-207-00-X |
polyhexamethylene biguanide hydrochloride |
|
27083-27-8 or 32289-58-0 |
Carc. Cat 3; R40 Xn; R22 T; R48/23 Xi; R41 R43 N; R50-53 |
T; N R: 22-40-41-43-48/23-50/53 S: (1/2-)22-36/37/39-45-60-61 |
N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C ≤ 2,5 % R52-53: 0,025 % ≤ C ≤ 0,25 % |
|
616-208-00-5 |
N-ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one |
220-250-6 |
2687-91-4 |
Repr. Cat. 2; R61 |
T R: 61 S: 45-53 |
|
|
616-209-00-0 |
amidosulfuron (ISO); 3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea |
407-380-0 |
120923-37-7 |
N; R50-53 |
N R: 50/53 S: 60-61 |
N; R50-53: C ≥ 0,25 % N; R51-53: 0,025 % ≤ C < 0,25 % R52-53: 0,0025 %≤ C < 0,025 % |
|
616-210-00-6 |
tebufenpyrad (ISO); N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide |
|
119168-77-3 |
Xn; R20/22 R43 N; R50-53 |
Xn; N R: 20/22-43-50/53 S: (2-)24-37-46-60-61 |
N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 % |
|
616-211-00-1 |
proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one |
|
189278-12-4 |
Carc. Cat. 3; R40 N; R50-53 |
Xn; N R: 40-50/53 S: (2-)36/37-46-60-61 |
|
|